BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+13.03%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$581M
AUM Growth
+$581M
Cap. Flow
+$19.1M
Cap. Flow %
3.28%
Top 10 Hldgs %
83.03%
Holding
29
New
5
Increased
5
Reduced
4
Closed
3

Top Buys

1
IRWD icon
Ironwood Pharmaceuticals
IRWD
$31.3M
2
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
$11.1M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.26M
4
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$6.06M
5
OMED
OncoMed Pharmaceuticals, Inc.
OMED
$6M

Top Sells

1
LGND icon
Ligand Pharmaceuticals
LGND
$20.3M
2
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
$15.8M
3
ARRY
Array Biopharma Inc
ARRY
$8.78M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
$7.51M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
$2.72M

Sector Composition

1 Healthcare 79.15%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LGND icon
1
Ligand Pharmaceuticals
LGND
$3.15B
$136M 23.48% 3,153,665 -468,000 -13% -$20.3M
IRWD icon
2
Ironwood Pharmaceuticals
IRWD
$214M
$93.6M 16.1% 7,896,061 +2,643,500 +50% +$31.3M
ARRY
3
DELISTED
Array Biopharma Inc
ARRY
$60.5M 10.4% 9,719,589 -1,412,269 -13% -$8.78M
RIGL icon
4
Rigel Pharmaceuticals
RIGL
$697M
$34.8M 5.99% 9,730,697 – –
GYRE icon
5
Gyre Therapeutics
GYRE
$703M
$32.8M 5.64% 6,171,669 – –
CCXI
6
DELISTED
ChemoCentryx, Inc.
CCXI
$29.9M 5.14% 5,377,616 +350,850 +7% +$1.95M
CASC
7
DELISTED
Cascadian Therapeutics, Inc.
CASC
$18.3M 3.14% 8,872,778 +779,500 +10% +$1.61M
EXEL icon
8
Exelixis
EXEL
$10.1B
$14.6M 2.51% 2,502,256 – –
CYTK icon
9
Cytokinetics
CYTK
$4.23B
$13M 2.24% 1,718,905 – –
TBRA
10
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$11.1M 1.91% +1,659,091 New +$11.1M
QLTI
11
DELISTED
QLT Inc
QLTI
$11M 1.89% 2,370,263 – –
AVNR
12
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$10.3M 1.78% 2,436,053 +1,430,000 +142% +$6.06M
RCPT
13
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$8.31M 1.43% 320,000 – –
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.26M 1.42% +545,372 New +$8.26M
ARQL
15
DELISTED
Arqule Inc
ARQL
$6.84M 1.18% 2,935,187 +302,755 +12% +$705K
SAVA icon
16
Cassava Sciences
SAVA
$110M
$6.41M 1.1% 2,357,327 – –
OMED
17
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$6M 1.03% +391,800 New +$6M
AGIO icon
18
Agios Pharmaceuticals
AGIO
$2.19B
$5.51M 0.95% +196,996 New +$5.51M
PTN
19
DELISTED
Palatin Technologies
PTN
$3.51M 0.6% 5,200,000 – –
SPHS
20
DELISTED
Sophiris Bio, Inc.
SPHS
$2.81M 0.48% +600,000 New +$2.81M
ANTH
21
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$2.25M 0.39% 559,624 -3,917,376 -88% -$15.8M
RGLS
22
DELISTED
Regulus Therapeutics
RGLS
$2.2M 0.38% 233,689 -32,756 -12% -$309K
GNVC
23
DELISTED
GenVec, Inc.
GNVC
$617K 0.11% 486,100 – –
PRTK
24
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$477K 0.08% 150,000 – –
AVDL
25
Avadel Pharmaceuticals
AVDL
$1.43B
– – -151,406 Closed -$931K
1
2